For individuals seeking help with opioid addiction, there are two primary FDA-approved medication options available through integrated treatment programs:

1. Buprenorphine Treatment: This is a partial opioid agonist that eases withdrawal symptoms and reduces cravings without producing an intense high. It is often administered via sublingual films or tablets. Because of its safety profile and ceiling effect, it is well-suited for office-based treatment and flexible outpatient schedules.

1. Methadone Treatment: This is a full opioid agonist that fully activates brain receptors to block withdrawal and cravings while preventing the euphoric effects of other opioids. It is typically administered as a daily oral liquid. Due to its potency and need for structured monitoring, it is often provided through certified clinics for those requiring more intensive stabilization.

Both options are most effective when combined with the three pillars of recovery: FDA-approved medications, clinical counseling, and behavioral therapies like cognitive-behavioral techniques. These programs are designed to normalize brain chemistry and support long-term recovery within outpatient, Partial Hospitalization (PHP), or Intensive Outpatient (IOP) settings.